There are conflicting data about the prognostic impact of IDH1/IDH2 mutations in AML; a meta-analysis of the literature data indicates that the presence of IDH mutations does not change AML prognosis [161]. This evidence concerns the gene IDH1 and acute myeloid leukemia.